These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status]. Song Y; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):273-6. PubMed ID: 11775905 [TBL] [Abstract][Full Text] [Related]
83. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma. Cade TJ; Quinn MA; Rome RM; Polyakov A Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561 [TBL] [Abstract][Full Text] [Related]
84. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma. Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251 [TBL] [Abstract][Full Text] [Related]
85. Prognostic value of progesterone receptors in endometrial cancer. Kleine WW Cancer Treat Res; 1994; 70():93-100. PubMed ID: 8060755 [No Abstract] [Full Text] [Related]
91. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Lax SF Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944 [TBL] [Abstract][Full Text] [Related]
92. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature. Kauppila A Acta Oncol; 1989; 28(4):561-6. PubMed ID: 2675940 [TBL] [Abstract][Full Text] [Related]